Neuronal membrane phospholipid metabolism and mitochondrial membrane integrity

Neuronal membrane phospholipid metabolism and mitochondrial membrane integrity refer to the biochemical maintenance of cellular boundaries and energy-producing organelles in the brain. This process is primarily driven by the Kennedy pathway, where citicoline (CDP-choline) serves as a rate-limiting intermediate for the synthesis of phosphatidylcholine, the most abundant phospholipid in neuronal membranes (Grieb, 2014, CNS Drugs). Maintaining mitochondrial membrane integrity is essential for preventing the release of pro-apoptotic factors and ensuring efficient oxidative phosphorylation (Adibhatla & Hatcher, 2005, J Neurosci Res). In conditions such as ischemic stroke or neurodegenerative diseases, the breakdown of these membranes leads to the accumulation of toxic free fatty acids and cellular death (Secades, 2011, Rev Neurol). Therapeutic agents like citicoline act by providing exogenous cytidine and choline to stimulate phospholipid synthesis and restore membrane structural integrity (PubChem, CID 13804). Consequently, this target represents a metabolic strategy for neuroprotection and cognitive enhancement rather than a single receptor or enzyme.

Other names

Phospholipid metabolismMitochondrial membrane maintenanceKennedy pathwayCDP-choline pathway

Drugs targeting this process, such as citicoline, provide precursors for the Kennedy pathway to increase the synthesis of phosphatidylcholine and sphingomyelin (Grieb, 2014, CNS Drugs). This action helps to repair damaged neuronal membranes and stabilize mitochondrial membranes by maintaining cardiolipin levels and inhibiting the activation of phospholipases that would otherwise degrade membrane lipids into toxic free fatty acids (Adibhatla & Hatcher, 2005, J Neurosci Res).